Tag: Xofluza

October 17, 2019 Off

Genentech gets FDA approval of Xofluza for risk of developing influenza-related complications

Genentech has received FDA’s approval of Xofluza, which is the first and only antiviral medicine indicated specifically for patients at…

July 3, 2019 Off

Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu

By BusinessWire

The MINISTONE-2 study showed XOFLUZA, given as a new oral suspension, is a well-tolerated and effective potential treatment for the flu in otherwise healthy children aged one to less than 12 years –